Home > NRC Library > ADAMS Public Documents

06-19183-01 621155 Boehringer Ingelheim Pharmaceuticals, Inc. (Financial Assurance)

Accession Number: ML20163A151

Date Released: Friday, July 31, 2020

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML20163A175 - Boehringer Ingelheim Pharmaceuticals, Inc.; Letter dated 04/22/2020 Re: Financial Assurance (1 page(s), 4/22/2020)
• ML20210M348 - Boehringer Ingelheim Pharmaceuticals, Inc., Telephone Conversation Record dated July 20, 2020, Subject: Discrepancy in Square Footage (1 page(s), 7/20/2020)
• ML20212L868 - Boehringer Ingelheim Pharmaceuticals, Inc.; Acceptance of Financial Assurance Submittal, Mail Control No. 621155 (3 page(s), 7/27/2020)